Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study
about
Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries.
P2860
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Safety and immunogenicity of a ...... II randomized controlled study
@ast
Safety and immunogenicity of a ...... II randomized controlled study
@en
type
label
Safety and immunogenicity of a ...... II randomized controlled study
@ast
Safety and immunogenicity of a ...... II randomized controlled study
@en
prefLabel
Safety and immunogenicity of a ...... II randomized controlled study
@ast
Safety and immunogenicity of a ...... II randomized controlled study
@en
P2093
P2860
P50
P1476
Safety and immunogenicity of a ...... II randomized controlled study
@en
P2093
Aino Forstén
Anitta Ahonen
Celine Monfredo
Cheng-Hsun Chiu
Enrique Rivas
Ilkka Seppä
Ilya Angélica Rochín Kobashi
Jerzy Brzostek
Josemund Menezes
Po-Yen Chen
P2860
P304
P356
10.1080/21645515.2016.1212143
P577
2016-08-26T00:00:00Z